Evidence map›Paper›PMID 32515118›Full record

Trial reportClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2020

Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma.

Andrew Wardlaw, Peter H Howarth, Elliot Israel, Camille Taillé, Santiago Quirce, Stephen Mallett, Stewart Bates, Frank C Albers, Namhee Kwon

Open access · hybridAbstract readClinical Trial, Phase IIILetterRandomized Controlled Trial
In one paragraph

Trial report in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Fungal Allergen and Mold Allergy Diagnosis: Role and Relevance ofJournal of fungi (Basel, Switzerland) · 2022
    Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Andrew WardlawInstitute for Lung Health, University of Leicester, Leicester, UK.
Peter H HowarthGlobal Medical Franchise, GSK House, Brentford, UK.
Elliot IsraelHarvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Camille TailléAP-HP, Hôpital Bichat, Service de Pneumologie et Centre de Référence des Maladies Pulmonaires Rares, Dépt Hospitalo-Universitaire FIRE, Université Paris Diderot, INSERM UMR, Paris, France.
Santiago QuirceDepartment of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), and CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.
Stephen MallettClinical Statistics, GSK, Uxbridge, UK.
Stewart BatesRespiratory Discovery Medicine, GSK, Stevenage, UK.
Frank C AlbersRespiratory Medical Franchise, GSK, Research Triangle Park, NC, USA.
Namhee KwonRespiratory Medical Franchise, GSK, Brentford, UK.ORCID 0000-0001-5238-0656
Age UK · GBBrigham and Women's Hospital · USHospital La Paz Institute for Health Research · ESInserm · FRResearch Triangle Park Foundation · USSouthampton General Hospital · GBUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaAdultAgedAntibodies, Monoclonal, HumanizedAspergillus fumigatusFemaleHumansMaleMiddle AgedPenicillium chrysogenumAntibodies, Monoclonal, Humanizedmepolizumab

Identifiers

PMID32515118
PMCPMC7540511
OpenAlexW3033362031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.